大庆华科股份有限公司 证券代码：000985 证券简称：大庆华科 公告编号：2024012 2、股东大会的召集人: 公司董事会。 3、会议召开的合法、合规性:本次会议召开符合公司法、证券法 及公司章程等法律、法规、部门规章、规范性文件及业务规则的相关 规定。 4、会议召开时间 （1）现场会议：2024 年 5 月 22 日（星期三）14:00 （2）网络投票 通过深圳证券交易所交易系统进行网络投票的具体时间为：2024 年 5 月 22 日 9:15-9:25，9:30—11:30 和 13:00—15:00；通过深圳 证券交易所互联网投票系统（http://wltp.cninfo.com.cn）进行网络投 票的具体时间为：开始投票的时间为 2024 年 5 月 22 日（现场股东大 会召开当日）上午 9：15，结束时间为 2024 年 5 月 22 日（现场股东 大会结束当日）下午 3：00。 5、会议召开方式：本次股东大会采用现场表决与网络投票相结 合的方式召开。 关于召开 2023 年年度股东大会的通知 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 一、召 ...

经审核，监事会认为公司董事会编制和审议 2023 年年度报告的 程序符合法律、行政法规及中国证监会的规定，报告内容真实、准确、 完整地反映了上市公司的实际情况，不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及 连带责任。 二、对公司 2024 年第一季度报告的审核意见 一、对大庆华科股份有限公司（以下简称"公司"）2023 年年度 报告的审核意见 大庆华科股份有限公司 监事会审核意见 三、对 2023 年度公司内部控制自我评价报告的审核意见。 2024 年 4 月 25 日 经审核，监事会认为董事会编制和审议公司 2024 年第一季度报 告的程序符合法律、行政法规及中国证监会的规定，报告内容真实、 准确、完整地反映了上市公司的实际情况，不存在任何虚假记载、误 导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性负个 别及连带责任。 公司监事会对公司内部控制制度的建设和运行情况进行了调查 和评估，对公司内部控制自我评价报告进行认真审核后认为：公司认 真落实《公司法》《证券法》《深圳证券交易所上市公司内部控制指引》 《企业内部控制基本规范》等法律法规及相关规定，建立健 ...

大庆华科股份有限公司 董事会对独立董事独立性评估的专项意见 大庆华科股份有限公司董事会 2024年4月25日 经核查独立董事王涌先生、李国峰先生、赵云宝先生、潘明先生 的任职经历以及签署的相关自查文件，上述人员及直系亲属、主要社 会关系均未在公司担任除独立董事以外的任何职务，也未在公司主要 股东公司担任任何职务；不存在为公司及控股股东或者其附属企业提 供财务、法律、咨询等服务的情形；与公司以及主要股东之间不存在 利害关系或其他可能妨碍其进行独立客观判断的关系，不存在影响独 立董事独立性的情况。符合《上市公司独立董事管理办法》《深圳证 券交易所上市公司自律监管指引第1号——主板上市公司规范运作》 中对独立董事独立性的相关要求。 根据中国证券监督管理委员会《上市公司独立董事管理办法》《深 圳证券交易所股票上市规则》《深圳证券交易所上市公司自律监管指 引第1号——主板上市公司规范运作》等要求，大庆华科股份有限公 司（以下简称"公司"）董事会，就公司在任独立董事王涌先生、李 国峰先生、赵云宝先生、潘明先生的独立性情况进行评估并出具如下 专项意见： ...

Dividend and Shareholder Information - The company plans to distribute a cash dividend of 0.18 RMB per 10 shares to all shareholders, based on a total of 129,639,500 shares [3]. - The largest shareholder, China Petroleum Daqing Oilfield, holds 55.03% of the shares, totaling 71,339,700 shares [139]. - Daqing High-tech State-owned Assets Operation Co., Ltd. holds 8.47% of the shares, totaling 10,980,900 shares, with 5,490,000 shares pledged [139]. - The total number of shareholders at the end of the reporting period is 10,560, with no changes in shareholding during the reporting period [139]. - The company has no restricted shares in circulation during the reporting period [141]. - The board approved a dividend payout of 0.5 RMB per share, reflecting a commitment to returning value to shareholders [79]. Financial Performance - The company's operating revenue for 2023 was ¥2,000,204,861.54, a decrease of 23.34% compared to ¥2,609,036,852.21 in 2022 [6]. - The net profit attributable to shareholders for 2023 was ¥5,676,684.90, down 63.16% from ¥15,408,919.20 in 2022 [6]. - The net profit excluding non-recurring gains and losses was ¥1,039,692.83, a decline of 91.31% from ¥11,958,066.78 in 2022 [6]. - The basic earnings per share for 2023 was ¥0.0438, down 63.19% from ¥0.119 in 2022 [6]. - The total operating cost for 2023 was ¥1,893,926,862.57, a decrease of 24.43% from ¥2,506,206,934.63 in 2022 [53]. - The company reported a total cash inflow from investment activities of CNY 1,681,287.50, a significant increase from CNY 106,312.50 in the previous year, highlighting improved investment recovery [170]. Operational Highlights - The company has undergone several changes in its business operations since its establishment in 1998, expanding into various sectors including healthcare products and chemical production [13]. - The company has established a complete product sales network, with sales primarily focused on Northeast China while also exporting to Southeast Asia and North America [43]. - The company achieved operating revenue of 2.00 billion yuan, with a total profit of 4.12 million yuan and a net profit of 5.68 million yuan for the reporting period [45]. - The company exported goods worth 596.87 million USD during the reporting period [45]. - The production facility's overall operational stability rate reached 97.59% during the reporting period [46]. Research and Development - The company holds a total of 16 national patents, including 11 invention patents, with core technologies for C5 and C9 petroleum resins being proprietary [44]. - Research and development expenses fell by 37.55% to ¥10,047,354.61, attributed to fewer projects entering trial production compared to 2022 [54]. - The number of R&D personnel decreased by 14.71% to 58, while their proportion of total employees increased slightly to 12.37% [55]. - The company is in the pilot stage of developing several new products, including high softening point carbon five resin and modified dicyclopentadiene petroleum resin, to diversify its product offerings [56]. - The company is investing 500 million RMB in R&D for new technologies aimed at improving production efficiency by 20% [79]. Market and Industry Outlook - The company expects the petrochemical industry to recover in 2024, driven by domestic demand and economic policies aimed at stabilizing growth [22]. - The market demand for C5 petroleum resins is expected to rise, particularly in road marking paint and hot melt adhesives, due to economic recovery and policy support [26]. - The domestic polypropylene production capacity increased by 13.73% year-on-year in 2023, reaching 39.76 million tons per year [31]. - The company plans to leverage technological innovation to improve production processes and enhance core competitiveness in the traditional industry [62]. - The company is expanding its market presence, with plans to enter three new international markets by the end of 2024 [93]. Governance and Compliance - The company maintains a complete and independent governance structure, ensuring compliance with relevant laws and regulations [67]. - The company has established independent financial management and accounting systems, ensuring financial autonomy [69]. - The company has maintained a stable governance structure with the election of new independent directors to ensure compliance and oversight [75]. - The company emphasizes the importance of internal control systems and decision-making processes to enhance overall governance [90]. - The company has a structured approach to ensure the protection of minority shareholders' rights during board decisions [90]. Environmental and Social Responsibility - The company invested a total of 6.8172 million yuan in environmental governance and protection during the reporting period [115]. - The company achieved a 100% compliance rate for the disposal of waste gas, waste water, and solid waste during the reporting period [111]. - The company has implemented measures to reduce carbon emissions, including optimizing production processes and improving fuel combustion efficiency [116]. - The company has established various emergency response plans for environmental incidents, which have been reviewed by experts and filed with relevant authorities [112]. - The company has maintained compliance with environmental protection laws and standards, as it is classified as a key pollutant discharge unit [108]. Financial Controls and Audit - The internal control system is deemed effective, with no major deficiencies identified during the reporting period [101]. - The audit opinion for the financial statements was a standard unqualified opinion, issued by Tianjian Accounting Firm on April 25, 2024 [151]. - The company is responsible for ensuring the financial statements are free from material misstatement due to fraud or error, emphasizing the importance of internal controls [160]. - The company’s financial reporting adheres to the relevant accounting standards, ensuring accurate initial measurement and subsequent measurement of financial assets and liabilities [187]. - The company maintains a robust framework for measuring and reporting financial instruments, ensuring compliance with applicable accounting standards [189].

大庆华科股份有限公司 关于中油财务有限责任公司风险评估报告 根据《企业集团财务公司管理办法》、深圳证券交易所 相关规定，大庆华科股份有限公司（以下简称"公司"）审 阅了中油财务有限责任公司（以下简称"中油财务"）2023 年度未经审计的财务报表及相关数据指标，并进行了相关的 风险评估，同时对中油财务的《金融许可证》《企业法人营 业执照》的合法有效性进行了查验，出具本风险评估报告。 一、基本情况 中油财务是中国人民银行下发了《关于筹建中油财务有 限责任公司的批复》（银复〔1995〕267 号），同意筹建中油 财务，于 1995 年 7 月 31 日取得营业执照及《中华人民共和 国金融许可证》。 （一）注册地址：北京市东城区东直门北大街 9 号中国 石油大厦 A 座 8 层-12 层 （二）经营场所：北京市东城区东直门北大街 9 号中国 石油大厦 A 座 8 层-12 层 （三）金融许可证机构编码：L0003H211000001 （四）统一社会信用代码：91110000100018558M （五）法定代表人：刘德 （六）注册资本：1,639,527.31 万元（除特殊说明外， 本议案金额单位均为人民币），股东构成 ...

目 录 | 一、内部控制审计报告…………………………………………第 | | --- | | 1—2 页 | 二、附件…………………………………………………………第 3—6 页 内部控制审计报告 天健审〔2024〕4133 号 大庆华科股份有限公司全体股东： 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求，我 们审计了大庆华科股份有限公司（以下简称大庆华科公司）2023 年 12 月 31 日 的财务报告内部控制的有效性。 一、企业对内部控制的责任 按照《企业内部控制基本规范》《企业内部控制应用指引》以及《企业内部 控制评价指引》的规定，建立健全和有效实施内部控制，并评价其有效性是大庆 华科公司董事会的责任。 二、注册会计师的责任 我们的责任是在实施审计工作的基础上，对财务报告内部控制的有效性发表 审计意见，并对注意到的非财务报告内部控制的重大缺陷进行披露。 三、内部控制的固有局限性 我们认为，大庆华科公司于 2023 年 12 月 31 日按照《企业内部控制基本规 第 1 页 共 6 页 范》和相关规定在所有重大方面保持了有效的财务报告内部控制。 天健会计师事务所（特殊普通合伙） 中国注册会计 ...

大庆华科股份有限公司 2023 年度独立董事述职报告 （潘 明） 作为大庆华科股份有限公司（以下简称"公司"）独立 董事，本人严格按照《公司法》《证券法》《上市公司治理 准则》《上市公司独立董事管理办法》《深圳证券交易所上 市公司自律监管指引第 1 号—主板上市公司规范运作》等有 关法律、法规和《公司章程》《独立董事工作制度》等相关 规定，本着恪尽职守、勤勉尽责的工作态度，积极出席公司 股东大会、董事会及各专门委员会，认真审议董事会各项议 案，扎实履行独立董事职责，并按规定对公司相关事项发表 了独立、客观、公正的意见，充分发挥独立董事的作用，维 护公司股东尤其是中小股东的合法利益。现将 2023 年度履 行职责的情况报告如下： 一、基本情况 截至 2023 年 12 月 31 日，本人基本情况如下： 潘明，男，1994 年 10 月出生，中国国籍，无境外永久 居留权，研究生学历，律师。历任黑龙江省上图教育科技有 限公司、黑龙江省法中教育科技有限公司法务助理、北京大 成（哈尔滨）律师事务所律师等职务。现任职北京市京师（哈 尔滨）律师事务所律师，2023 年 2 月起任公司独立董事。 作为公司的独立董事，本人未在 ...

大庆华科股份有限公司 2023 年度内部控制自我评价报告 大庆华科股份有限公司 2023 年度内部控制自我评价报告 大庆华科股份有限公司全体股东： 根据《企业内部控制基本规范》及其配套指引的规定和其他内部 控制监管要求（以下简称企业内部控制规范体系），结合公司内部控 制制度和评价办法，在内部控制日常监督和专项监督的基础上，我们 对公司2023年12月31日（内部控制评价报告基准日）的内部控制有效 进行了评价。 一、重要声明 按照企业内部控制规范体系的规定，建立健全和有效实施内部控 制，评价其有效性，并如实披露内部控制评价报告是公司董事会的责 任。监事会对董事会建立和实施内部控制进行监督，经理层负责组织 领导企业内部控制的日常运行，公司董事会、监事会及董事、监事、 高经管理人员保证本报告内容不存在任何虚假记载、误导性陈述或重 大遗漏，并对报告内容的真实性、准确性和完整性承担个别及连带法 律责任。 二、内部控制评价结论 根据公司财务报告内部控制重大缺陷的认定情况，于内部控制评 价报告基准日，不存在财务报告内部控制重大缺陷。董事会认为，公 司已按照企业内部控制规范体系和相关规定的要求在所有重大方面 保持了有效的财务 ...

Financial Performance - The company's operating revenue for Q1 2024 was ¥482,819,586.36, a decrease of 23.26% compared to ¥629,173,594.69 in the same period last year[3] - Net profit attributable to shareholders increased by 61.66% to ¥3,674,785.42 from ¥2,273,226.83 year-on-year[3] - The net profit after deducting non-recurring gains and losses surged by 200.49% to ¥4,878,906.14 compared to ¥1,623,668.20 in the previous year[3] - Basic and diluted earnings per share increased by 55.56% to ¥0.028 from ¥0.018 year-on-year[3] - Net profit for Q1 2024 reached ¥3,674,785.42, representing a 61.6% increase from ¥2,273,226.83 in Q1 2023[13] Cash Flow and Liquidity - The net cash flow from operating activities rose by 35.97% to ¥31,620,128.89 from ¥23,254,404.49 in the same period last year[3] - Cash and cash equivalents increased to ¥336,208,944.19 from ¥311,039,784.58 at the beginning of the period, reflecting a growth of 8.1%[10] - Total cash and cash equivalents at the end of the period rose to ¥336,208,944.19 from ¥248,525,268.02, reflecting an increase of approximately 35.2%[16] - Operating cash inflow decreased to ¥609,995,258.38 from ¥721,515,486.55, a decline of approximately 15.5%[15] - The company’s cash flow from operating activities showed improvement, contributing to the increase in net profit despite lower revenues[13] Assets and Liabilities - Total assets at the end of the reporting period were ¥697,675,337.62, a slight decrease of 0.61% from ¥701,936,697.20 at the end of the previous year[3] - Total liabilities decreased to ¥108,292,096.09 from ¥115,879,760.43, a reduction of 6.5%[11] - Inventory decreased to ¥56,163,350.13 from ¥71,262,027.71, indicating a decline of 21.2%[10] - Shareholders' equity attributable to the parent company increased by 0.57% to ¥589,383,241.53 from ¥586,056,936.77 at the end of the previous year[3] Non-Recurring Items and Expenses - The company reported a non-recurring loss of ¥1,204,120.72, primarily due to non-current asset disposal losses[4] - The company reported a significant reduction in research and development expenses, which were ¥0.00 in Q1 2024 compared to ¥3,427,151.44 in Q1 2023[13] Shareholder Information - The total number of common shareholders at the end of the reporting period was 9,926[5] - The largest shareholder, China Petroleum Daqing Petrochemical Co., Ltd., holds 55.03% of the shares[5] Future Outlook and Strategy - The company plans to focus on market expansion and new product development in the upcoming quarters to drive growth[13] - The company is expected to continue focusing on operational efficiency and cash flow management in the upcoming quarters[17] - No new products or technologies were mentioned in the report, indicating a potential area for future development[17] Audit and Reporting - The report was unaudited, suggesting that the figures may be subject to change upon final audit[16] - Cash flow from financing activities was not detailed in the report, indicating no significant changes in financing strategies[16] - The company did not report any net profit from subsidiaries prior to consolidation, maintaining a consistent performance in this area[14]